Fresenius Medical Care & KGaA Statistics Share Statistics Fresenius Medical Care & KGaA has 586.83M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 586.83M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 11.94% Shares Floating 586.39M Failed to Deliver (FTD) Shares 3,618 FTD / Avg. Volume 0.92%
Short Selling Information The latest short interest is 1.46M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.46M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 7.06
Valuation Ratios The PE ratio is 23.89 and the forward
PE ratio is 9.79.
Fresenius Medical Care & KGaA's PEG ratio is
3.12.
PE Ratio 23.89 Forward PE 9.79 PS Ratio 0.66 Forward PS 0.6 PB Ratio 0.88 P/FCF Ratio 7.62 PEG Ratio 3.12
Financial Ratio History Enterprise Valuation Fresenius Medical Care & KGaA has an Enterprise Value (EV) of 16.25B.
EV / Sales 0.84 EV / EBITDA 5.07 EV / EBIT 6.81 EV / FCF 9.64
Financial Position The company has a current ratio of 1.4,
with a Debt / Equity ratio of 0.75.
Current Ratio 1.4 Quick Ratio 1.03 Debt / Equity 0.75 Debt / EBITDA 3.42 Debt / FCF 6.51 Interest Coverage 3.42
Financial Efficiency Return on Equity is 3.69% and Return on Invested Capital is 3.35%.
Return on Equity 3.69% Return on Assets 1.6% Return on Invested Capital 3.35% Revenue Per Employee $172.59K Profits Per Employee $4.8K Employee Count 112,035 Asset Turnover 0.58 Inventory Turnover 7.05
Taxes Income Tax 316.06M Effective Tax Rate 29.9%
Stock Price Statistics The stock price has increased by 32.87% in the
last 52 weeks. The beta is 0.86, so Fresenius Medical Care & KGaA's
price volatility has been higher than the market average.
Beta 0.86 52-Week Price Change 32.87% 50-Day Moving Average 27.19 200-Day Moving Average 24.69 Relative Strength Index (RSI) 30.36 Average Volume (20 Days) 393,156
Income Statement In the last 12 months, Fresenius Medical Care & KGaA had revenue of 19.34B
and earned 537.91M
in profits. Earnings per share was 0.92.
Revenue 19.34B Gross Profit 4.76B Operating Income 1.39B Net Income 537.91M EBITDA 3.21B EBIT 1.46B Earnings Per Share (EPS) 0.92
Full Income Statement Balance Sheet The company has 1.15B in cash and 10.98B in
debt, giving a net cash position of -9.83B.
Cash & Cash Equivalents 1.15B Total Debt 10.98B Net Cash -9.83B Retained Earnings 11.27B Total Assets 31.29B Working Capital 2.48B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 2.39B
and capital expenditures -699.36M, giving a free cash flow of 1.69B.
Operating Cash Flow 2.39B Capital Expenditures -699.36M Free Cash Flow 1.69B FCF Per Share 2.87
Full Cash Flow Statement Margins Gross margin is 24.6%, with operating and profit margins of 7.2% and 2.78%.
Gross Margin 24.6% Operating Margin 7.2% Pretax Margin 5.47% Profit Margin 2.78% EBITDA Margin 16.58% EBIT Margin 7.2% FCF Margin 8.72%
Dividends & Yields FMS pays an annual dividend of $0.79,
which amounts to a dividend yield of 2.71%.
Dividend Per Share $0.79 Dividend Yield 2.71% Dividend Growth (YoY) 24.12% Payout Ratio 60.08% Earnings Yield 4.19% FCF Yield 26.25%
Dividend Details Analyst Forecast The average price target for FMS is $30,
which is 24.5% higher than the current price. The consensus rating is "Hold".
Price Target $30 Price Target Difference 24.5% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $4.6 Lynch Upside -80.9% Graham Number 45.19 Graham Upside 87.59%
Stock Splits The last stock split was on Dec 4, 2012. It was a
forward
split with a ratio of 2:1.
Last Split Date Dec 4, 2012 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 1.88 Piotroski F-Score 8
